Magnesium sulfate ( DrugBank: Magnesium sulfate, Magnesium, Sulfate )

3 diseases

ID	Disease name (Link within this page)	Number of trials
11	Myasthenia gravis	1
296	Biliary atresia	1
297	Alagille syndrome	1

11. Myasthenia gravis

Clinical trials : 332 / Drugs : 234 - (DrugBank : 81) / Drug target genes : 45 - Drug target pathways : 127

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	ChiCTR1800017696	2016-07-01	2018-08-10	Effect of Magnesium Sulfate on Muscle Strength in Patients with Myasthenia Gravis	Effect of Magnesium Sulfate on Muscle Strength in Patients with Myasthenia Gravis	Myasthenia Gravis	Group A:Magnesium Sulfate;Group B:Normal saline;	The University of Hong Kong-Shenzhen Hospital	NULL	Recruiting	18	60	Both	Group A:30;Group B:30;		China

Clinical trials : 71 / Drugs : 70 - (DrugBank : 39) / Drug target genes : 35 - Drug target pathways : 60

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00007033 (ClinicalTrials.gov)	October 2000	6/12/2000	Study of Magnesium Sulfatein Children With Reduced Bone Density Secondary to Chronic Cholestatic Liv ...		Alagille Syndrome;Cholestasis;Biliary Atresia	Drug: magnesium gluconate;Drug: magnesium sulfate	National Center for Research Resources (NCRR)	Children's Hospital Medical Center, Cincinnati	Completed	3 Years	18 Years	Both	25	N/A	United States

Clinical trials : 45 / Drugs : 21 - (DrugBank : 10) / Drug target genes : 3 - Drug target pathways : 5

diseases per page:

Showing 1 to 1 of 1 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00007033 (ClinicalTrials.gov)	October 2000	6/12/2000	Study of Magnesium Sulfatein Children With Reduced Bone Density Secondary to Chronic Cholestatic Liv ...		Alagille Syndrome;Cholestasis;Biliary Atresia	Drug: magnesium gluconate;Drug: magnesium sulfate	National Center for Research Resources (NCRR)	Children's Hospital Medical Center, Cincinnati	Completed	3 Years	18 Years	Both	25	N/A	United States